StockStory.org on MSN2 小时
EMCOR (NYSE:EME) Misses Q4 Sales Targets, But Stock Soars 7.7%Specialty construction contractor company EMCOR (NYSE:EME) in Q4 CY2024, but sales rose 9.6% year on year to $3.77 billion.
Recovering South Korean shopaholic-turned-climate activist Lee So-yeon used to buy new clothes almost daily — until a $1.50 ...
New internal development team Bad Guitar Studio is made up of young, hardcore FPS fans, and after joining them for a one-hour ...
Before and after a briefly-flickering career, athletes get saddled with the pursuit of 'sports quota' jobs. Badminton coach ...
Back in 2016, we featured a stunning wooden machine that employed falling steel marbles to play a merry tune. As plans are ...
To allow more focus on its higher-end in-house calibers, Yema launches the Superman Swiss Edition ✓ Read about this strategic ...
Nikola Jović has grown into a vital piece for the Heat, but his broken hand deals another test for Miami's challenging season ...
Apprentices at GROB Systems Inc. in Bluffton spend two years in training, either in the mechanical or electrical pathway, ...
Josephine Cochran revolutionised kitchen cleaning by inventing the first practical dishwasher, forever transforming ...
A team of researchers in Japan says it has developed a robot hand that moves using cultivated human muscle tissues and is the ...
The Missouri Tigers baseball were plagued with a strong start from the UCF Knights and weren't able to figure out a way back.
The revolutionary BiVACOR heart device was moved to Phase 2 of FDA trials after success in five human patients.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果